Nectar Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled to be held on July 23, 2021 to consider and approve the Audited Financial Results for the Financial Year 2020-21, Financial Statements of the Company for the Financial Year 2020-21 and matters related thereto; to convene the Annual General Meeting of Members of the Company for the Financial Year 2020-21 and matters related thereto; and to fix Book Closure dates for the purpose of Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
